Activists and 5% owners

Item 4, purpose of the transaction: The Reporting Persons acquired the shares of Common Stock reported herein because they believe that the shares of Common Stock are undervalued and represent an attractive investment opportunity. On September 10, 2026, the Oasis Fund delivered to the Issuer a notice (the "Nomination Notice") of its intention to nominate Mr. Chapek, Mr. Hudson, Mr. Roberts, and Ms. Street (collectively, the "Nominees") for election to the Board at the Issuer's 2026 annual meeting of stockholders (the "2026 Annual Meeting"). The Reporting Persons believe the Issuer controls an irreplaceable portfolio of 42 world-class mountain resorts - a collection of scarce, high-quality assets that, in the Reporting Person…

Item 4, purpose of the transaction: GL II has the right to acquire warrants to purchase up to $99,000,000 of additional shares of XCF Class A Common Stock until December 31, 2026. The price for each warrant is set forth in the Warrant Purchase Agreement entered into between GL II and XCF on July 16, 2026. Each warrant is exercisable on a paid or cashless basis at $2.50 per share. The Reporting Persons may purchase and sell common stock of XCF in their sole discretion and at such times as they deem convenient, subject to applicable law.

Item 4, purpose of the transaction: This Schedule 13D relates to shares of Common Stock of the Issuer held in the account of LP, of which GP is the general partner. Management serves as the investment manager of LP and may direct the vote and disposition of the 225,010,000 shares of Common Stock held by LP. As the sole managing member of Management, Mr. Mohs may direct the vote and disposition of the 225,010,000 shares of Common Stock held by LP. On August 19, 2026, the board of directors of Issuer adopted resolutions declaring it advisable and in the best interests of the Issuer to amend the Articles of Incorporation to authorize 500,000,000 shares of Common Stock and 5,000,000 shares of Preferred Stock. On September 11, 20…

Item 4, purpose of the transaction: The Reporting Persons purchased the aforementioned securities for investment purposes with the aim of increasing the value of their investments and the Issuer. Subject to applicable legal requirements, one or more of the Reporting Persons may purchase additional securities of the Issuer from time to time in open market or private transactions, depending on its evaluation of the Issuer's business, prospects and financial condition, the market for the Issuer's securities, other developments concerning the Issuer, the reaction of the Issuer to the Reporting Persons' ownership of the Issuer's securities, other opportunities available to the Reporting Persons, and general economic, money market …

Item 4, purpose of the transaction: On February 12, 2026, the Sponsor paid $25,000, or approximately $0.014 per share, to cover certain of the Issuer's offering costs in exchange for 1,725,000 Founder Shares (the "Founder Shares"), of which 225,000 founder shares were forfeited subject to the expiration of the underwriters' over-allotment option, pursuant to the Securities Subscription Agreement dated as of February 12, 2026 between the Sponsor and the Issuer (the "Founder Share Purchase Agreement"). On April 20, 2026, the Issuer consummated its initial public offering ("IPO") and in connection with the consummation, Sponsor purchased an aggregate of 300,000 private placement shares for an aggregate purchase price of $3,000,00…

Item 4, purpose of the transaction: The Reporting Persons hold the securities reported herein for investment purposes and in the capacities further described below. Dr. Bokhari acquired, and holds, such securities both directly, and through his control of RBx Capital, LP, as applicable, in connection with his service as Executive Chairman and Chief Executive Officer of the Issuer, and as an initial investor in the securities of the Issuer at the time of its reverse take-over transaction as described in the Issuer's filings with the Commission. In his capacity as Executive Chairman and Chief Executive Officer of the Issuer, Dr. Bokhari participates in the management and direction of the business and affairs of the Issuer and, …

Item 4, purpose of the transaction: The Reporting Person acquired the Series A-1 Preferred in connection with his service as CEO and director. Each share carries 100 votes and is convertible at the Reporting Person's option, at any time, into one (1) share of common stock (a one-for-one basis; up to 4,000,000 shares in the aggregate). As a result, the Reporting Person holds 460,437,500 votes (comprised of 400,000,000 votes from the Series A-1 Preferred, 50,000,000 votes from the Reporting Person's 500,000 shares of Series A Preferred Stock, and 10,437,500 votes from the Reporting Person's 10,437,500 directly held shares of Common Stock - 10,125,000 per the Empire Stock Transfer account statement dated April 8, 2026, plus …

Item 4, purpose of the transaction: The Reporting Persons acquired the securities reported herein for investment purposes. The Common Stock issued on September 2, 2026 was received in satisfaction of accrued dividends payable on the Issuer's Series A Preferred Stock in accordance with the terms of the Certificate of Designation. The Reporting Persons may, from time to time, depending upon market conditions, the Issuer's business and prospects, and other relevant factors, acquire additional securities of the Issuer or dispose of securities of the Issuer. Except as described in this Schedule 13D, the Reporting Persons have no present plans or proposals that relate to or would result in any of the matters described in Items 4(…

Item 4, purpose of the transaction: The Reporting Person acquired the securities for investment purposes. Depending on market conditions and other factors, the Reporting Person may from time to time acquire additional securities of the Issuer or dispose of securities of the Issuer in the ordinary course of investment. Except as described in this Schedule 13D, the Reporting Person has no present plans or proposals that relate to or would result in any of the matters described in Items 4(a) through (j) of Schedule 13D.

Item 4, purpose of the transaction: The purpose of the acquisition of Shares by the Reporting Person is for investment as part of the general investment portfolio of the Reporting Person. This Schedule 13D is being filed because the Reporting Person is no longer a member of a "group" within the meaning of Section 13(d)(3) of the Act, as disclosed in the explanatory note to this Schedule 13D. This filing is not being made as a result of any particular acquisition or disposition of securities by the Reporting Person. The Reporting Person intends to review her investments in the Issuer on a continuing basis and may, at any time, consistent with the Reporting Person's obligations under the federal securities laws, determine to in…

Item 4, purpose of the transaction: The Reporting Persons own 19.99% of the Company in the aggregate, based upon the Company's aggregate outstanding shares as of September 8, 2026. The Reporting Persons' securities include (a) 2,691 shares of Common Stock issuable upon the exercise of options held directly by Mr. Kiselak that are currently exercisable or will be exercisable within 60 days of the date of this filing, (b) 6,911,174 shares of Common Stock directly held by Fund II and (c) 2,192,555 shares of Common Stock directly held by Co-Invest, and exclude (i) 2,074,000 shares of Common Stock issuable upon conversion of 2,074 shares of Series B Preferred Stock directly held by Fund II and (ii) 66,436 shares of Common Stock iss…

Item 4, purpose of the transaction: On March 23, 2026, the Issuer issued 2,875,000 ordinary shares (the "Founder Shares") to the Sponsor for the purchase price of $25,000. On June 29, 2026, the Company effected a 1 for 1.33333 share split of the Founder Shares, resulting in Sponsor holding 3,833,333 Founder Shares. On August 20, 2026, Sponsor agreed to transfer an aggregate of 75,000 shares to director nominees of the Issuer, Messrs. Jeffrey A. Dunham, Jeffrey G. Brock and Jameson Culp. On September 2, 2026, the Issuer consummated its initial public offering ("IPO") and in connection with the consummation of the IPO, Sponsor purchased an aggregate of 200,000 private placement units, each consisting of one ordinary share and o…

Item 4, purpose of the transaction: The information set forth or incorporated by reference in Item 6 of this Schedule 13D is incorporated by reference into this Item 4. The Reporting Persons intend to further assess their investment in the Issuer from time to time, on the basis of various factors, including, without limitation, the Issuer's business performance, financial condition, results of operations and prospects, general economic, market and industry conditions, as well as other developments and other investment opportunities available to the Reporting Persons and the Issuer. The Reporting Persons seek to maximize the value of their investment in the Issuer. If the Reporting Persons believe that further investment in th…

Item 4, purpose of the transaction: The information reported in Item 3 of this Schedule 13D is incorporated by reference into this Item 4. As described in more detail in Item 6, below, under the caption "Board Appointment Rights," Purchaser obtained certain rights to nominate a member of Issuer's board of directors (the "Board"). Pursuant to such rights, Purchaser nominated Jacky Wu to the Board, and the Board in turn elected Mr. Wu as a member with effect from the closing of the Private Placement. Mr. Wu is not otherwise associated with the Reporting Persons and is independent of the Company's management. The Reporting Persons intend to participate in the management of the Issuer in the ordinary course of business and consi…

Item 4, purpose of the transaction: The Reporting Person acquired the securities described in this Schedule 13D pursuant to the transactions and agreements with the Issuer discussed in Item 3 of this Schedule 13D, which is incorporated herein by reference. In connection with the transactions contemplated by the SPA, immediately prior to the execution of the SPA on April 27, 2026, the Reporting Person was appointed to the Issuer's Board as a Class II director with a term expiring at the Issuer's 2027 annual meeting of stockholders. At the Issuer's special meeting of stockholders reconvened on July 17, 2026, the Issuer's stockholders approved, among other matters, the issuance of shares of Common Stock, upon conversion of the P…

Item 4, purpose of the transaction: The Reporting Person acquired the securities of the Issuer pursuant to a Securities Purchase Agreement, dated as of August 3, 2026, by and among ARC Group International Ltd., Conglin (Forrest) Deng, the Chief Executive Officer of the Issuer, Bridgeforrest (BVI) Inc., a British Virgin Islands holding company ("BBI"), Alwin Creative Inc., a British Virgin Islands company of which Mr. Deng is the sole Director, and Abits Group Inc. (the "Purchase Agreement"). The Reporting Person acquired the Shares (including indirectly through its purchase of the ownership interests in BBI) for investment purposes. Among other things, the Purchase Agreement provided that, effective at closing of the purchase…

Item 4, purpose of the transaction: The Reporting Person acquired the Common Stock to which this Schedule 13D relates in connection with the Merger and the Private Placement. The information contained in Item 3 of this Schedule 13D is incorporated hereunder by reference. The Reporting Person serves as the General Counsel and Secretary and a Director of the Issuer. Accordingly, the Reporting Person may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of Schedule 13D. Subject to the Lock-Up Agreement described in Item 6 of this Schedule 13D, the Reporting Person may, from time to time, purchase or sell securities of the Issuer…

Item 4, purpose of the transaction: The Reporting Persons acquired beneficial ownership of the securities reported herein for investment purposes. The Reporting Persons may engage in discussions with management, the board, or other shareholders regarding the Issuer's operations, governance, or strategic alternatives. The Reporting Persons may acquire additional securities of the Issuer or dispose of securities depending on market conditions and other factors. Except as set forth above, the Reporting Persons do not have any current plans or proposals which would result in any of the matters listed in Item 4(a) - (j) of Schedule 13D.

Item 4, purpose of the transaction: The Reporting Person acquired the Common Shares for investment purposes through a series of related transactions, each of which is described below, as well as to effect the transfer of the Reporting Person's then wholly-owned subsidiary, Fort Products Limited, a private company incorporated under the laws of England and Wales ("Fort UK"), into a publicly traded vehicle, thereby providing Fort UK with access to public capital markets, enhanced liquidity and a platform for the continued growth and expansion of its e-commerce consumer products business, while enabling the Reporting Person to retain a controlling equity interest in the combined enterprise and to continue to support the Issuer's …

Item 4, purpose of the transaction: The Reporting Person acquired the Common Stock to which this Schedule 13D relates in connection with the Merger. The information contained in Item 3 of this Schedule 13D is incorporated hereunder by reference. The Reporting Person serves as the Vice President of Business and a Director of the Issuer. Accordingly, the Reporting Person may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of Schedule 13D. Subject to the Lock-Up Agreement described in Item 6 of this Schedule 13D, the Reporting Person may, from time to time, purchase or sell securities of the Issuer as appropriate for his perso…

Item 4, purpose of the transaction: The Reporting Person acquired the Common Stock to which this Schedule 13D relates in connection with the Merger and the Private Placement. The information contained in Item 3 of this Schedule 13D is incorporated hereunder by reference. The Reporting Person serves as the President and Chief Executive Officer and a Director of the Issuer. Accordingly, the Reporting Person may have influence over the corporate activities of the Issuer, including activities that may relate to items described in clauses (a) through (j) of Item 4 of Schedule 13D. Subject to the Lock-Up Agreement described in Item 6 of this Schedule 13D, the Reporting Person may, from time to time, purchase or sell securities of th…

Item 4, purpose of the transaction: The Reporting Persons intend to review the performance of their investment in the Issuer from time to time. Depending on various factors, including the business, prospects and financial position of the Issuer, the current and anticipated future price levels of the Common Stock and currency exchange rates, the conditions in the securities markets and general economic and industry conditions, as well as the other investment opportunities available to them, each of the Reporting Persons will take such actions with respect to their investment in the Issuer as they deem appropriate in light of the circumstances existing from time to time. Each of the Reporting Persons may purchase additional equi…

Item 4, purpose of the transaction: The information set forth in Items 3 and 6 of this Schedule 13D is hereby incorporated by reference into this Item 4. Mr. Woodman serves as Chief Executive Officer and Chairman of the Board of Directors of the Issuer and, in such capacity, may have influence over the corporate activities of the Issuer, including activities which may relate to items described in subparagraphs (a) through (j) of Item 4 of Schedule 13D. The Reporting Person may from time to time buy or sell securities of the Issuer as appropriate for his personal circumstances. The Reporting Persons, either directly or indirectly through Mr. Woodman, may engage in discussions from time to time with the Issuer's board of direc…

Item 4, purpose of the transaction: Merger On April 22, 2026, Helix Energy Solutions Group, Inc., a Minnesota corporation ("Helix"), Hornbeck Offshore Services, Inc., a Delaware corporation ("Legacy Hornbeck"), and certain subsidiaries of Helix entered into an Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement"), pursuant to which a wholly owned subsidiary of Helix merged with and into Legacy Hornbeck (the "first merger"), with Legacy Hornbeck surviving, and Legacy Hornbeck immediately merged with and into another wholly owned subsidiary of Helix, with that subsidiary surviving as a wholly owned subsidiary of Helix (the "Mergers"). Immediately prior to the Mergers, Helix converted from…

Item 4, purpose of the transaction: The information set forth in Item 6 of this Schedule 13D with respect to the Securities Purchase Agreement, the Stockholder Agreement, the Lock-Up Agreement and the Registration Rights Agreement is incorporated by reference into this Item 4. General The Reporting Persons intend to review their investments in the Issuer on a continuing basis. Any actions the Reporting Persons might undertake will be dependent upon the Reporting Persons' review of numerous factors, including, but not limited to: an ongoing evaluation of the Issuer's business, financial condition, operations and prospects; price levels of the Issuer's securities; general market, industry and economic conditions; the relative …